Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases

<table class="table-group" width="800px"><tr class="fig-image" id="a"><td><img alt="945861.fig.003a" src="https://static.hindawi.com/articles/ad/volume-2011/945861/figures/945861.fig.003a.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(a) </b>Entire autoimmune (SLE + IBD) cohort</td></tr></table></td></tr><tr class="fig-image" id="b"><td><img alt="945861.fig.003b" src="https://static.hindawi.com/articles/ad/volume-2011/945861/figures/945861.fig.003b.jpg"/></td></tr><tr class="fig-caption"><td align="center"><table><tr><td><b>(b) </b>IBD cohort</td></tr></table></td></tr></table>

<table>Correlation of DNase I activity with the level of antinucleosomal antibodies. DNase I: deoxyribonuclease I; Ab: antibodies.</table>

Autoimmune Diseases

fig3

Figure 3

Figure 3: Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases 